PlainRecalls

Aurobindo Pharma USA Inc

59 recalls on record · Latest: Aug 12, 2026

Subscribe to new Aurobindo Pharma USA Inc recalls (RSS)

Agency notice ledger

Federal filing book Aurobindo Pharma USA Inc MID-BOOK · SINGLE-AGENCY

#298 of 14,151 · 59 notices · 0.057% archive

  • BOOK 59 notices
  • RANK #298 of 14,151
  • SHARE 0.057% archive
  • AGENCY FDA Drug (59)
  • CAT drugs
  • CATS 2 categories
  • LATEST Aug 12, 2026
  • PHOTO American Health Packa…

Nearest notice-volume peer: American Health Packaging (0 notice gap)

Aurobindo Pharma USA Inc accounts for about 0.057% of the 104,423-notice archive on 59 distinct filings — a heavy share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Aurobindo Pharma USA Inc compares to 14,151 recalling firms

Aurobindo Pharma USA Inc ranks 298th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Aurobindo Pharma USA Inc vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

59 298th of 14151 higher than 13,847 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Aurobindo Pharma USA Inc in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Aurobindo Pharma USA Inc holds about 0.057% of archive notices alongside 59 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Jan 23, 2019

Amlodipine and Valsartan Tablets USP 5 mg/160 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-737-30

FDA Drug Moderate Jan 23, 2019

Valsartan and Hydrochlorothiazide tablets USP 80 mg/12.5 mg, 90-count bottle, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-547-90.

FDA Drug Moderate Jan 23, 2019

Amlodipine and Valsartan Tablets USP 10 mg/160 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-739-30.

FDA Drug Low Dec 12, 2018

Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg, Rx only, 30-count bottle, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 0852 Made in India, NDC 65862-855-30

FDA Drug Moderate Feb 22, 2017

Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 072 India, NDC 65862-527-30

FDA Drug Low Feb 15, 2017

Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: Auromedics Pharma LLC 6 Wheeling Road, Dayton, NJ 08810, NDC 55150-202-00

FDA Drug Moderate Sep 21, 2016

Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx Only, 90 tablets per bottle, Manufactured for Aurobindo Pharma USA, Inc 2400 Route 130 North Dayton, NJ 08810, Manufactured by: Aurobindo Pharma Limited Unit-VII (SE2), Mahaboob Nagar (Dt) - 509302, India , NDC 65862-0560-90

FDA Drug Moderate Jan 14, 2015

Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141; Manufactured by: Aurobindo Pharma Limited, Unit-VII (SEZ), Mahaboob Nagar (Dt), AP-509302, INDIA, NDC 16714-662-01, UPC 3 16714-662-01 5.

FDA Drug Low Jun 5, 2013

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

Aurobindo Pharma USA Inc carries an outsized archive share

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Frequently Asked Questions

How many federal recall notices name Aurobindo Pharma USA Inc?
PlainRecalls indexes 59 distinct federal recall events naming Aurobindo Pharma USA Inc, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Aurobindo Pharma USA Inc sit among other recalling firms?
Aurobindo Pharma USA Inc ranks #298 of 14,151 by distinct recall-event count among 14,151 firms in this archive (98th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Aurobindo Pharma USA Inc's notices?
FDA Drug accounts for 59 of this firm's 59 indexed notices.
What product category dominates Aurobindo Pharma USA Inc's filing book?
Filings for Aurobindo Pharma USA Inc span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous?
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Aurobindo Pharma USA Inc: 59 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Aurobindo Pharma USA Inc; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026